Dexcom launches over-the-counter continuous glucose sensors in the US

Dexcom DXCM.O said on Monday its over-the-counter continuous glucose monitor, Stelo, is now available for use in the United States at a price of up to $99.

Stelo was cleared by the US health regulator in March for use by adults aged 18 and older who do not use insulin, making it the the first continuous glucose monitor available for over-the-counter sales.

Patients could buy a pack of two sensors at a one-time price of $99 or opt for a subscription to get a monthly delivery for $89, Dexcom said.

In June, rival Abbott Laboratories ABT.Nreceived the regulator's clearance for two similar devices, Libre Rio and Lingo, for adults with and without diabetes, respectively.

Abbott had said it plans to launch Lingo in the US this summer.

Lingo has been available in Britain since January for 120-150 pounds ($152-$190) per month.

Dexcom's Stelo uses a wearable sensor, paired with an application on the user's smartphone or other smart device to continuously measure blood glucose levels.

The device is not for individuals with problematic hypoglycemia or low blood sugar as it is not designed to alert the user about this potentially dangerous condition.